Tofacitinib citrate and Deformity - a phase IV clinical study of FDA data

Summary:

Deformity is reported as a side effect among people who take Tofacitinib citrate (tofacitinib citrate), especially for people who are female, 40-49 old, also take Enbrel, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Deformity when taking Tofacitinib citrate. It is created by eHealthMe based on reports of 7,765 people who have side effects when taking Tofacitinib citrate from the FDA, and is updated regularly.

What is Tofacitinib citrate?

Tofacitinib citrate has active ingredients of tofacitinib citrate. eHealthMe is studying from 7,767 Tofacitinib citrate users. Check the latest studies of Tofacitinib citrate.

What is Deformity?

Deformity (disfigurement) is found to be associated with 933 drugs and 701 conditions by eHealthMe. Check the latest studies of Deformity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

7,765 people reported to have side effects when taking Tofacitinib citrate.
Among them, 44 people (0.57%) have Deformity.

Could Tofacitinib citrate cause Deformity?

Among these 44 people:

What is the gender of people who have Deformity when taking Tofacitinib citrate? *

female: 100 %
male: 0.0 %

What is the age of people who have Deformity when taking Tofacitinib citrate? *

What are other drugs people take besides Tofacitinib citrate? *

What are other side effects people have besides Deformity? *

Joint Pain: 44 people, 100.00%
Malaise (a feeling of general discomfort or uneasiness): 43 people, 97.73%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 43 people, 97.73%
Drug Intolerance (drug sensitivity): 43 people, 97.73%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 42 people, 95.45%
Pain In Extremity: 42 people, 95.45%
Drug Ineffective: 42 people, 95.45%
Rash Pruritic (redness with itching): 41 people, 93.18%
Pain: 41 people, 93.18%
Gastric Ulcer (stomach ulcer): 41 people, 93.18%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 44 people, 100.00%
Pain: 27 people, 61.36%
Inflammation: 10 people, 22.73%
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 9 people, 20.45%
Fibromyalgia (a long-term condition which causes pain all over the body): 8 people, 18.18%
Back Pain: 7 people, 15.91%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 9.09%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Tofacitinib citrate and have Deformity?

- Check whether Deformity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tofacitinib citrate:

Tofacitinib citrate (7,767 reports)

Deformity treatments and more:

Deformity (13,758 reports)

Browse all side effects of Tofacitinib citrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deformity:

Deformity (933 drugs)

Browse all the conditions that are associated with Deformity:

Deformity (701 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Tofacitinib citrate) and Tofacitinib citrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.